Republika Południowej Afryki -
angielski -
South African Health Products Regulatory Authority (SAHPRA)
trisporal capsules
janssen pharmaceutica (pty) ltd - capsules - see ingredients - each capsule contains itraconazole 100,0 mg
Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
itraconazole 10mg/ml oral solution
athlone pharmaceuticals limited - itraconazole - oral solution - triazole derivatives; itraconazole
Republika Południowej Afryki -
angielski -
South African Health Products Regulatory Authority (SAHPRA)
vicomyl 200 mg iv #n/a
viatris south africa (pty) ltd - #n/a - not indicated - none
Singapur -
angielski -
HSA (Health Sciences Authority)
scemblix film-coated tablet 20 mg
novartis (singapore) pte ltd - asciminib hydrochloride eqv asciminib - tablet, film coated - asciminib hydrochloride eqv asciminib 20mg
Singapur -
angielski -
HSA (Health Sciences Authority)
scemblix film-coated tablet 40 mg
novartis (singapore) pte ltd - asciminib hydrochloride eqv asciminib - tablet, film coated - asciminib hydrochloride eqv asciminib 40 mg
Kanada -
angielski -
Health Canada
scemblix tablet
novartis pharmaceuticals canada inc - asciminib (asciminib hydrochloride) - tablet - 20mg - asciminib (asciminib hydrochloride) 20mg
Kanada -
angielski -
Health Canada
scemblix tablet
novartis pharmaceuticals canada inc - asciminib (asciminib hydrochloride) - tablet - 40mg - asciminib (asciminib hydrochloride) 40mg
Malezja -
angielski -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
scemblix 40mg film-coated tablet
novartis corporation (malaysia) sdn. bhd. - asciminib hydrochloride -
Izrael -
angielski -
Ministry of Health
scemblix 20 mg
novartis israel ltd - asciminib as hydrochloride - film coated tablets - asciminib as hydrochloride 20 mg - asciminib - scemblix is indicated for the treatment of adult patients with:• philadelphia chromosome-positive chronic myeloid leukemia (ph+ cml) in chronic phase (cp), previously treated with two or more tyrosine kinase inhibitors (tkis).• ph+ cml in cp with the t315i mutation
Izrael -
angielski -
Ministry of Health
scemblix 40 mg
novartis israel ltd - asciminib as hydrochloride - film coated tablets - asciminib as hydrochloride 40 mg - asciminib - scemblix is indicated for the treatment of adult patients with:• philadelphia chromosome-positive chronic myeloid leukemia (ph+ cml) in chronic phase (cp), previously treated with two or more tyrosine kinase inhibitors (tkis).• ph+ cml in cp with the t315i mutation